Abstract
Neurodegenerative diseases represent one of the most devastating types of diseases in older populations in our time. Significant efforts have been made over the last 20 years to understand the molecular, biochemical, and physiological alterations underlying these diseases. However, in most cases, little is known about their pathological mechanisms due to their high complexity and involvement of a multiplicity of cellular pathways. To gain insight into this group of disorders and to devise potential therapeutic approaches, cellular and animal models of neurodegenerative proteinopathies have been created. Among them, the yeast Saccharomyces cerevisiae has been one of the most popular model organisms due to the degree of conservation of many biological pathways from yeast to human as well as its ease of use. Here, we describe how to create yeast models of neurodegenerative proteinopathies by ectopic expression of human proteins and how to perform a basic characterization of these models by analyzing cellular toxicity and protein aggregation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Botstein, D. (1991) Why yeast Hosp. Pract. (Off. Ed.) 26, 157–61.
Miller-Fleming, L., Giorgini, F., and Outeiro, T. F. (2008) Yeast as a model for studying human neurodegenerative disorders Biotechnol. J. 3, 325–38.
Khurana, V., and Lindquist, S. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker’s yeast? Nat. Rev. Neurosci. 11, 436–49.
Middendorp, O., Luthi, U., Hausch, F., and Barberis, A. (2004) Searching for the most effective screening system to identify cell-active inhibitors of beta-secretase Biol. Chem. 385, 481–5.
Caine, J., Sankovich, S., Antony, H., Waddington, L., Macreadie, P., Varghese, J., and Macreadie, I. (2007) Alzheimer’s Abeta fused to green fluorescent protein induces growth stress and a heat shock response FEMS Yeast Res. 7, 1230–6.
Krobitsch, S., and Lindquist, S. (2000) Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins Proc. Natl. Acad. Sci. USA 97, 1589–94.
Meriin, A. B., Zhang, X., He, X., Newnam, G. P., Chernoff, Y. O., and Sherman, M. Y. (2002) Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1 J. Cell Biol. 157, 997–1004. Epub 10 June 2002.
Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., and Muchowski, P. J. (2005) A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease Nat. Genet. 37, 526–31.
Outeiro, T. F., and Lindquist, S. (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology Science 302, 1772–5.
Chen, Q., Thorpe, J., and Keller, J. N. (2005) Alpha-synuclein alters proteasome function, protein synthesis, and stationary phase viability J. Biol. Chem. 280, 30009–17. Epub 7 June 2005.
Dixon, C., Mathias, N., Zweig, R. M., Davis, D. A., and Gross, D. S. (2005) Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast Genetics 170, 47–59.
Johnson, B. S., McCaffery, J. M., Lindquist, S., and Gitler, A. D. (2008) A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity Proc. Natl. Acad. Sci. USA 105, 6439–44.
Myers, A. M., Pape, L. K., and Tzagoloff, A. (1985) Mitochondrial protein synthesis is required for maintenance of intact mitochondrial genomes in Saccharomyces cerevisiae EMBO J. 4, 2087–92.
Ocampo, A., and Barrientos, A. (2008) From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders Biotechniques 45, vii–xiv.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ocampo, A., Barrientos, A. (2011). Developing Yeast Models of Human Neurodegenerative Disorders. In: Manfredi, G., Kawamata, H. (eds) Neurodegeneration. Methods in Molecular Biology, vol 793. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-328-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-61779-328-8_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-327-1
Online ISBN: 978-1-61779-328-8
eBook Packages: Springer Protocols